SCOPUS 정보 검색 플랫폼

Pediatric Infectious Disease Journal

Volumn 27, Issue 1, 2008, Pages 69-70

Passive antibody prophylaxis for RSV

(1) DeVincenzo, John a

a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER (United States)

Author keywords

Bronchiolitis; Infant; Pneumonia; Prophylaxis; Respiratory syncytial virus

Indexed keywords

ANTIBODY; MONOCLONAL ANTIBODY; PALIVIZUMAB; PLACEBO; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY;

CLINICAL TRIAL; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; HIGH RISK PATIENT; HUMAN; INFECTION RISK; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RISK REDUCTION; SHORT SURVEY; UNSPECIFIED SIDE EFFECT; VIRUS INFECTION;

EID: 37549031737 PISSN: 08913668 EISSN: None Source Type: Journal
DOI: 10.1097/INF.0b013e318160921e Document Type: Review

Times cited : (4)

References (12)

1
- 0022589125
- Risk of primary infection and reinfection with RSV
- Glezen WP, et al. Risk of primary infection and reinfection with RSV. Am J Dis Child. 1986;140:543-546.
- (1986) Am J Dis Child , vol.140 , pp. 543-546
- Glezen, W.P.¹

2
- 0033638924
- Rates of hospitalization for RSV . .
- Boyce TG, et al. Rates of hospitalization for RSV . . .. J Pediatr 2000;137:865-870.
- (2000) J Pediatr , vol.137 , pp. 865-870
- Boyce, T.G.¹

3
- 0036020209
- RSV-coded pediatric hospitalizations
- Leader S, et al. RSV-coded pediatric hospitalizations. Pediatr Infect Dis J 2002;21:629-632.
- (2002) Pediatr Infect Dis J , vol.21 , pp. 629-632
- Leader, S.¹

4
- 0033949819
- RSV infection in adults
- Falsey AR, et al. RSV infection in adults. Clin Microbiol Rev. 2000;13:371-384.
- (2000) Clin Microbiol Rev , vol.13 , pp. 371-384
- Falsey, A.R.¹

5
- 0027384670
- Prophylactic administration of RSV-IG . .
- Groothuis JR, et al. Prophylactic administration of RSV-IG . . .. N Engl J Med 1993;329:1524-1530.
- (1993) N Engl J Med , vol.329 , pp. 1524-1530
- Groothuis, J.R.¹

6
- 0002443687
- Reduction of RSV hospitalization . .
- The PREVENT Study Group
- The PREVENT Study Group. Reduction of RSV hospitalization . . .. Pediatrics. 1997;99:93-99.
- (1997) Pediatrics , vol.99 , pp. 93-99

7
- 0031683919
- Palivizumab, a humanized RSV monoclonal . .
- The IMpact-RSV Study Group
- The IMpact-RSV Study Group. Palivizumab, a humanized RSV monoclonal . . .. Pediatrics. 1998;102:531-537.
- (1998) Pediatrics , vol.102 , pp. 531-537

8
- 0242298724
- Palivizumab prophylaxis. . . in children with congenital heart disease
- Feltes TF, et al. Palivizumab prophylaxis. . . in children with congenital heart disease. J Pediatr. 2003;143:532-540.
- (2003) J Pediatr , vol.143 , pp. 532-540
- Feltes, T.F.¹

9
- 0026502787
- Protective activity of RSV immune globulin . .
- Siber GR, et al. Protective activity of RSV immune globulin . . .. J Infect Dis. 1992;165:456-463.
- (1992) J Infect Dis , vol.165 , pp. 456-463
- Siber, G.R.¹

10
- 16944363559
- Development of a humanized monoclonal antibody (MEDI-493) . .
- Johnson S, et al. Development of a humanized monoclonal antibody (MEDI-493) . . .. J Infect Dis. 1997;176:1215-1224.
- (1997) J Infect Dis , vol.176 , pp. 1215-1224
- Johnson, S.¹

11
- 0347320936
- Revised indications for the use of palivizumab . .
- Committee on Infectious Disease
- Committee on Infectious Disease, et al. Revised indications for the use of palivizumab . . .. Pediatrics. 2003;112:1442-1446.
- (2003) Pediatrics , vol.112 , pp. 1442-1446

12
- 37549013192
- Phase 3 Trial of motavizumab (MEDI-524)
- Abstract 8220.9
- Carbonell X, et al. Phase 3 Trial of motavizumab (MEDI-524) . . .. PAS (Toronto). 2007; Abstract 8220.9 (#226).
- (2007) PAS (Toronto) , Issue.226
- Carbonell, X.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.